Surviving Pneumonia
Part of Hormones & metabolism, Infections, Lungs & breathing clinical trials.
This trial studies treatment for pneumonia by enrolling people who have pneumonia signs on a chest X-ray plus typical symptoms like fever, cough, trouble breathing, or chest pain. It may help doctors test approaches for better outcomes after pneumonia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a chest X-ray showing pneumonia-type changes (an “infiltrate”).
- You also have at least one pneumonia symptom, such as fever, new cough, trouble breathing, chest pain with breathing, or abnormal/changed breath sounds.
- You must be able to give informed consent (or otherwise have consent provided in a way allowed by the study).
- You must be willing to participate and agree to the study procedures.
- If you cannot give or do not want to give consent, you cannot join the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at adults with community-acquired pneumonia, using symptom checks and chest X-ray results. It may help researchers better understand what pneumonia looks like in the community and how it progresses.
This trial tests two noninvasive breathing support methods (NIV and HVNI) for people with pneumonia who are having trouble breathing. The goal is to see which method works better to help you avoid needing a breathing tube.
This study looks at medical records from adults who have pneumonia with a confirmed germ, to better understand how the disease develops and how people recover. It may help guide future care decisions.
This study is looking at adults with pneumonia to better understand how severe the infection is and how it may affect recovery. By joining, you will help doctors learn more about predicting outcomes for people with similar conditions.
This study follows how community-acquired pneumonia progresses in hospitalized patients who already have serious health problems or weakened immune systems. The goal is to better understand risk and changes over time, which may help guide future care for people like you.
This study tests a pneumococcal vaccine designed for 20 types of bacteria in older adults who are hospitalized with suspected community-acquired pneumonia. It aims to see how the vaccine works in real-world care and whether it affects how pneumonia happens or progresses.
Hear when a new Community-acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.